The estimated Net Worth of Dawn Mattoon is at least $2.16 Milion dollars as of 1 April 2022. Dawn Mattoon owns over 261 units of Quanterix Corp stock worth over $445,093 and over the last 7 years he sold QTRX stock worth over $412,993. In addition, he makes $1,302,420 as Senior Vice President - Research Products at Quanterix Corp.
Dawn has made over 45 trades of the Quanterix Corp stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 261 units of QTRX stock worth $7,775 on 1 April 2022.
The largest trade he's ever made was exercising 18,396 units of Quanterix Corp stock on 7 June 2021 worth over $405,632. On average, Dawn trades about 982 units every 23 days since 2018. As of 1 April 2022 he still owns at least 36,876 units of Quanterix Corp stock.
You can see the complete history of Dawn Mattoon stock trades at the bottom of the page.
Dr. Dawn R. Mattoon Ph.D serves as Senior Vice President - Research Products of the Company. She has been our Senior Vice President, Research Products since March 2019 and served as Senior Vice President of Strategic Marketing and Assay Technologies from February 2018 to March 2019. Dr. Mattoon completed both her Ph.D. and postdoctoral work at Yale University, studying tyrosine kinase signaling pathways. Following her postdoctoral fellowship in 2004, she joined Invitrogen, where she was recognized as one of the company's best new scientists in 2005. Dr. Mattoon went on to serve in a variety of leadership roles in R&D, Program & Portfolio Management, Strategy, and General Management as Invitrogen evolved to become Life Technologies with the acquisition of Applied Biosystems in 2008, and was subsequently acquired by Thermo Fisher in 2013. Until her departure from Thermo Fisher in 2014, Dr. Mattoon also served on global leadership teams focused on mentoring and developing female leaders. Dr. Mattoon served as the Vice President for Product Development at Cell Signaling Technologies, a leading antibody provider, from July 2014 to February 2018, after which she joined Quanterix.
As the Senior Vice President - Research Products of Quanterix Corp, the total compensation of Dawn Mattoon at Quanterix Corp is $1,302,420. There are 4 executives at Quanterix Corp getting paid more, with E. Kevin Hrusovsky having the highest compensation of $3,631,000.
Dawn Mattoon is 47, he's been the Senior Vice President - Research Products of Quanterix Corp since 2019. There are 18 older and 3 younger executives at Quanterix Corp. The oldest executive at Quanterix Corp is Dr. David R. Walt Ph.D., 68, who is the Co-Founder, Chairman of Scientific Advisory Board & Independent Director.
Dawn's mailing address filed with the SEC is C/O QUANTERIX CORPORATION,, 900 MIDDLESEX TURNPIKE, BILLERICA, MA, 01821.
Over the last 7 years, insiders at Quanterix Corp have traded over $25,118,881 worth of Quanterix Corp stock and bought 1,481,095 units worth $18,701,541 . The most active insiders traders include David R Walt, Paul M Meister oraz Keith Crandell. On average, Quanterix Corp executives and independent directors trade stock every 7 days with the average trade being worth of $100,483. The most recent stock trade was executed by Masoud Toloue on 13 August 2024, trading 19,000 units of QTRX stock currently worth $207,100.
quanterix offers an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. the single molecule array (simoa™) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more. quanterix is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at tufts university by dr. david walt, scientific founder of quanterix and illumina (nasdaq: ilmn).
Quanterix Corp executives and other stock owners filed with the SEC include: